Hercules Capital

Hercules Capital

Yahoo Finance • 13 days ago

2 Reasons HTGC is Risky and 1 Stock to Buy Instead

2 Reasons HTGC is Risky and 1 Stock to Buy Instead Hercules Capital trades at $16.95 and has moved in lockstep with the market. Its shares have returned 19.4% over the last six months while the S&P 500 has gained 22.1%. Is there a buying... Full story

Yahoo Finance • 18 days ago

Here's Why Hercules Capital (HTGC) Fell More Than Broader Market

Hercules Capital (HTGC) closed at $16.97 in the latest trading session, marking a -1.45% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.76%. Elsewhere, the Dow saw a downswing of 0.68%, while the... Full story

Yahoo Finance • 20 days ago

Q2 Rundown: Hercules Capital (NYSE:HTGC) Vs Other Specialty Finance Stocks

Q2 Rundown: Hercules Capital (NYSE:HTGC) Vs Other Specialty Finance Stocks Looking back on specialty finance stocks' Q2 earnings, we examine this quarter's best and worst performers, including Hercules Capital (NYSE:HTGC) and its peers.... Full story

Yahoo Finance • 24 days ago

Hercules Capital (HTGC) Advances But Underperforms Market: Key Facts

In the latest close session, Hercules Capital (HTGC) was up +1.08% at $17.76. The stock's performance was behind the S&P 500's daily gain of 1.14%. Meanwhile, the Dow gained 0.61%, and the Nasdaq, a tech-heavy index, added 1.69%. The spec... Full story

Yahoo Finance • 25 days ago

Want $1,500 In Passive Income? Invest $5,000 In Each of These 4 Dividend Stocks

Quick Read A $20,000 split across Realty Income (O) and NNN REIT (NNN) yields 5.53% and 5.74%, generating $277 and $287 annually. Gladstone Commercial (GOOD) and Hercules Capital (HTGC) supercharge the portfolio with 9.43% and 10.65% yiel... Full story

Yahoo Finance • last month

Hercules Capital (HTGC) Suffers a Larger Drop Than the General Market: Key Insights

Hercules Capital (HTGC) ended the recent trading session at $17.39, demonstrating a -1.25% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of 0.59%. Meanwhile, the Dow lost 0.6%, and... Full story

Yahoo Finance • last month

How to Build $9,400 a Month in Dividend Income Without Selling a Single Share

Quick Read Hitting $112,800 annually in dividends demands $3.22M at conservative yields but just $1.06M from high-yield BDCs and mortgage REITs. A 3.5% dividend yield growing 8% annually doubles income in nine years without adding a singl... Full story

Yahoo Finance • last month

How a 78-Year-Old Collects $5,300 a Month From Just Three Tickers: SCHD, HTGC, and NNN

Quick Read SCHD, NNN, and HTGC each hit $63,600 annually but require vastly different capital: $2.19M, $1.18M, and $589,000 respectively. SCHD's ~8% annual dividend growth can double income in roughly nine years, far outpacing HTGC's dist... Full story

Yahoo Finance • 2 months ago

3 BDCs Yielding Big. A Roth Is the Only Place They Make Sense

Quick Read BDC distributions hit your 1099 as ordinary income, turning a $50,000 yield into $38,000 after federal taxes at the 24% bracket. ARCC and HTGC yield 9.6% and 11%, and sheltering either in a Roth saves $12,000 annually versus ho... Full story

Yahoo Finance • 3 months ago

Dyne Therapeutics (DYN) Inspires Confidence With Its Force Platform

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 10 affordable biotech stocks to buy right now. On June 26, TD Cowen initiated its coverage of Dyne Therapeutics Inc. (NASDAQ:DYN), assigning a Buy rating to the stock. The firm stated that... Full story

Yahoo Finance • 3 months ago

Lexicon Pharmaceuticals (LXRX) Gains on Russell 3000 Inclusion

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has gained more than 15% over the past month, mainly driven by the stock's inclusion in the Russell 3000 index and strong Q1 2026 earnings. Wall Street expects more than 21% upside over the next... Full story

Yahoo Finance • 4 months ago

2 Reasons to Avoid HTGC and 1 Stock to Buy Instead

2 Reasons to Avoid HTGC and 1 Stock to Buy Instead Over the past six months, Hercules Capital's stock price fell to $15.30. Shareholders have lost 16.9% of their capital, which is disappointing considering the S&P 500 has climbed by 8.5%.... Full story

Yahoo Finance • 5 months ago

Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 11, 2026, Citi raised the firm’s price target on Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) to $3.10 from $2.30 and maintained a... Full story

Yahoo Finance • 5 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hercules Capital, Inc. of Class Action Lawsuit and Upcoming Deadlines – HTGC

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hercules Capital, Inc. (“Hercules” or the “Company”) (NYSE: HTGC). Such investors are advised to contact Danielle Peyto... Full story

Yahoo Finance • 5 months ago

Important Notice to Long-Term Shareholders of Hercules Capital Inc. (NYSE: HTGC); LKQ Corporation (NASDAQ: LKQ); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, May 19, 2026 (GLOBE NEWSWIRE) -- HERCULES CAPITAL INC. (NYSE: HTGC): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Hercules Capital Inc. (NYSE: HTGC). The investigation concerns... Full story

Yahoo Finance • 5 months ago

DEADLINE ALERT for GEMI, PSIX, HTGC, LU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the de... Full story

Yahoo Finance • 5 months ago

Deadline Alert: Hercules Capital, Inc. (HTGC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 19, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or oth... Full story

Yahoo Finance • 5 months ago

HTGC DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hercules Capital, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 19 Deadline in Securities Class Action - HTGC

NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1, 2025 and February 27, 2026, inclusive (the “Class... Full story

Yahoo Finance • 5 months ago

HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hercules Capital, Inc. (“Hercules” or “the Company”) (NYSE: HTGC) viola... Full story

Yahoo Finance • 5 months ago

DEADLINE ALERT for IT, PSIX, GEMI, and HTGC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, May 18, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the d... Full story